AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on the overdose epidemic from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on the overdose epidemic from PolicyFinder
AMA in Action: Ending the overdose epidemic

End the Epidemic website
Clear Search
·
11 Min Read

Experts discuss the pandemic’s impact on the opioid epidemic

The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.

series
Behavioral Health
AMA Update
Poster for naloxone
·
6 Min Read

COVID-19 may be worsening opioid crisis, but states can take action

The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.

Behavioral Health
·
2 Min Read

May 22, 2020: State Advocacy Update

State reports of increased opioid-related mortality continue to increase in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

May 15, 2020: State Advocacy Update

Opioid epidemic may be worsening; states must implement federal flexibility in the latest State Advocacy Update.

Advocacy Update
·
10 Min Read

April 17, 2020: National Advocacy Update

Advocacy spotlights new cyber treats during COVID-19 and physician protections as well as new policies for opioid treatment programs.

Advocacy Update
Man wearing a face mask
·
3 Min Read

New policies on treating pain, OUD emerge from COVID-19 crisis

The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.

Behavioral Health
·
2 Min Read

AMA urges governors to adopt DEA guidance for opioid use disorder

This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.

Press Releases
·
2 Min Read

AMA recommends exceptions to facilitate opioid use disorder treatment

The blanket exception will allow patients to obtain up to 28 days of take-home medication if they are stable and up to 14 days for patients who are less stable.

Press Releases
Patient speaking with physician
·
4 Min Read

New York effort raises use of MAT for opioid-use disorder

Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.

Behavioral Health